U.S., April 14 -- ClinicalTrials.gov registry received information related to the study (NCT07525427) titled 'Bactericidal Activity of TBD09 in Combination With Other Drugs in Pulmonary Tuberculosis' on April 01.
Brief Summary: The purpose of this study is to evaluate if TBD09 in combination with other active agents in adults with drug sensitive pulmonary tuberculosis has potential to be safe and effective.
Study Start Date: April 10
Study Type: INTERVENTIONAL
Condition:
Drug Susceptible Pulmonary Tuberculosis
Intervention:
DRUG: Bedaquiline, pretomanid and TBD09
Group 1 (30 participants): The combination of TBD09 (100 mg three times weekly, TIW), bedaquiline (200 mg daily, QD), and pretomanid (200 mg QD), 28 days
DRUG: Bedaquiline...